Donors pledge over $170 million to WHO ahead of US exit

The World Health Organization (WHO) secured over $170 million in pledges from countries including China, Qatar, and Switzerland, along with acceptance of higher fees from member states, to mitigate the financial impact of the United States' planned withdrawal, which previously accounted for 18% of the WHO's funding. This comes as the WHO has already revised its 2026-2027 budget down by a fifth and increased countries' mandatory fees by 20% over the next two years, potentially making China the top state donor.

Analysis

The World Health Organization is navigating a significant financial transition following the United States' planned withdrawal, which previously accounted for 18% of its funding. To mitigate this, the WHO has secured over $170 million in new pledges for 2025-2028 from nations including Switzerland ($40 million), Sweden ($13.5 million), and Qatar ($6 million), in addition to an earlier $500 million commitment from China. Concurrently, member states have approved a 20% increase in mandatory fees over the next two years, a measure aimed at bolstering the organization's financial stability. Despite these efforts, the WHO has revised its 2026-2027 budget downwards by a fifth to $4.2 billion and implemented management post reductions, reflecting the fiscal pressures. This financial restructuring is occurring alongside a geopolitical shift, with China poised to become the WHO's top state donor, a development highlighted by China's health minister as a signal of support during the reform process. The US administration, however, remains critical, with Health Secretary Robert F. Kennedy Jr. describing the WHO as "moribund". The overall situation underscores an ongoing effort to reform the WHO's funding model, making it less reliant on a few large donors, a sentiment echoed by Germany's call for prompt reforms to safeguard the organization.

Key Decisions for Investors

• Investors in the pharmaceutical and biotech sectors should monitor how the WHO's revised $4.2 billion budget and new funding structure, including China's increased role as top donor, will influence global health priorities and procurement, potentially impacting market opportunities.
• Assess the implications of China becoming the WHO's top state donor, including potential shifts in health policy focus and procurement patterns, which may create new opportunities or challenges for companies in the global health supply chain.
• Consider the impact of the WHO's overall budget reduction by a fifth, despite new pledges exceeding $170 million and a 20% rise in mandatory fees, as this necessitates prioritization that could affect funding for specific disease areas or health system strengthening efforts relevant to healthcare investments.